SCHEDULE: SymBiosis Capital Partners Discloses 6.3% Stake in Generation Bio

SymBiosis Capital Partners, LLC has reported a 6.3% beneficial ownership stake in Generation Bio Co.'s common stock as of September 30, 2025.

Summary

• SymBiosis Capital Partners, LLC has acquired beneficial ownership of 421,926 shares of Generation Bio Co. Common Stock.
• This ownership represents 6.3% of the total class of securities.
• The shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of Generation Bio Co.
• SymBiosis Capital Partners, LLC, a Delaware entity, holds sole voting and sole dispositive power over all 421,926 shares.
• The date of the event requiring this filing was September 30, 2025.

Sentiment

Score: 6

Explanation: The filing is largely neutral as it is a passive ownership disclosure. However, the emergence of a new institutional investor with a significant stake can be viewed as a moderately positive signal of confidence in the company.

Positives

• A new institutional investor, SymBiosis Capital Partners, LLC, has taken a significant 6.3% stake in Generation Bio Co., potentially signaling confidence in the company's future prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Generation Bio Co. or SymBiosis Capital Partners, LLC regarding the issuer's future performance.

Management Comments

• SymBiosis Capital Partners, LLC certified that the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of Generation Bio Co.

Industry Context

The disclosure of a new significant institutional investor in Generation Bio Co., a company likely in the biotechnology sector given its name, suggests continued investor interest in the life sciences and gene therapy space. Such investments can be a bellwether for sector sentiment.

Stakeholder Impact

• Shareholders may perceive the new institutional ownership by SymBiosis Capital Partners, LLC as a positive indicator of confidence in Generation Bio Co.'s valuation and future prospects.

Key Dates

Recommendation

The Schedule 13G filing indicates a new significant passive stake by SymBiosis Capital Partners, LLC in Generation Bio Co. While this signals institutional confidence, the filing itself does not provide operational or financial performance details to warrant a stronger recommendation. Investors should 'hold' and await further operational updates or financial reports to assess the company's fundamentals.

Keywords

Generation Bio Co., SymBiosis Capital Partners, Common Stock, Schedule 13G, Beneficial Ownership, Institutional Investor, Biotechnology